Donald J. Santel

Insider Reports History

Location
San Francisco, CA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donald J. Santel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12,500 $204,625 $16.37 05 Jun 2024 Direct
Surrozen, Inc./DE Former Director Common Stock 30,000 $11,400 $0.3800 11 Aug 2021 Direct
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 03 Jan 2023 Direct
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 03 Jan 2023 Direct
Surrozen, Inc./DE Former Director Class B Ordinary Shares 0 11 Aug 2021 Direct

Insider Reports Filed by Donald J. Santel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JBIO Aerovate Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 02 Jan 2024 1 +$38,973 4 Director 04 Jan 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 19 Jan 2023 2 +$38,994 4 Director 23 Jan 2023, 17:02
JBIO Aerovate Therapeutics, Inc. 19 Jan 2023 0 $0 3 Director 23 Jan 2023, 16:59
/report/000120919123001092-santel-donald-j-2023-01-03 Oyster Point Pharma, Inc. 03 Jan 2023 4 $0 4 Director 04 Jan 2023, 16:08
/report/000120919122035055-santel-donald-j-2022-06-06 Oyster Point Pharma, Inc. 06 Jun 2022 2 $0 4 Director 08 Jun 2022, 16:43
SRZN Surrozen, Inc./DE 11 Aug 2021 2 $0 4 Former Director 13 Aug 2021, 19:39
/report/000120919121049492-santel-donald-j-2021-07-30 Oyster Point Pharma, Inc. 30 Jul 2021 4 $0 4 Director 03 Aug 2021, 20:18
/report/000120919121049490-santel-donald-j-2021-07-30 Oyster Point Pharma, Inc. 30 Jul 2021 0 $0 3 Director 03 Aug 2021, 20:14